Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 44
Filter
4.
Arch Geschwulstforsch ; 52(4): 293-301, 1982.
Article in English | MEDLINE | ID: mdl-7138241

ABSTRACT

Material of 150 patients with Hodgkin's disease was demonstrated and analyzed as to the prognostic significance of factors such as clinical advancement of the disease, histology, sex and age. Median survival time differed significantly in various clinical stages, being in I-III A stages as long as 8.0 years, in III B--5.5 and in IV B--3.4. Median survival time in relative to histologic pattern did not differ significantly in spite of fact that that of LD form was about 2 years shorter than of 3 remaining types. Mean but not median survival time of women was significantly longer than that of men: women were at presentation at less advanced clinical stages and in LD type showed more favourable clinical course than men, but not in NS type. Presence of systemic symptoms was also determinant of worse prognosis. It was observed that simultaneous incidence of unfavourable prognostic factor as LD histology, male sex and advanced clinical stage markedly worsened prognosis.


Subject(s)
Hodgkin Disease/mortality , Adolescent , Adult , Age Factors , Aged , Female , Hodgkin Disease/pathology , Humans , Male , Middle Aged , Neoplasm Staging , Poland , Prognosis , Sex Factors
9.
Arch Immunol Ther Exp (Warsz) ; 27(4): 461-8, 1979.
Article in English | MEDLINE | ID: mdl-92973

ABSTRACT

By using specific anti-CEA serum and indirect immunofluorescence, a substance was detected in breast cancers which reacted similarly to CEA demonstrable by the same method in cancers of gastrointestinal tract. However, the double diffusion test in agar gel and additional absorption analysis showed that it was a glycoprotein different from CEA, although possessing common or similar antigenic determinants with it. This antigen also differs from another antigen called "nonspecific cross-reacting antigen NCA" and from alpha 1-acid glycoprotein of human serum.


Subject(s)
Adenocarcinoma/immunology , Adenofibroma/immunology , Breast Neoplasms/immunology , Carcinoembryonic Antigen/analysis , Cross Reactions , Epitopes , Female , Humans , Intestinal Neoplasms/immunology , Neoplasm Metastasis , Stomach Neoplasms/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...